Patient Centricity on Trial - Trial Patient Focus Group

On Thursday 30th May, we hosted a focus group where we brought together patients, carers, industry advocates and more to discuss the trial patient experience and how considering every aspect of this can lead to trial success.


Episode 3: Finding the right treatment for the patient

Professor Andrew Biankin (Regius Chair of Surgery/Director of Translational Research Centre, University of Glasgow)

Professor Biankin, a world leader in pancreatic cancer, is unearthing the genetic and molecular secrets hidden within the biggest collection of pancreatic tumour samples in the world. His findings could lead to better ways of matching therapies to patients, and uncover new avenues for treatment. Increasing survival from pancreatic cancer is one of our top priorities, and research like Professor Biankin’s is vital to help more people survive. In this talk, Professor Biankin discusses the importance of finding the very best treatment for the patient, with a focus on Precision Oncology, understanding the data and how this can be applied and shared.


Patient centricity on trial focus group highlights

On Thursday 30th May, we hosted a focus group where we brought together patients, carers, industry advocates and more to discuss the trial patient experience and how considering every aspect of this can lead to trial success.


Episode 2: Alder Play

Cameron Day (ustwo)

Alder Hey Children’s Hospital were looking to provide their patients with an enhanced and personalised experience, that could make their time in the hospital less daunting and more enjoyable. They wanted to set the global benchmark for a child’s healthcare journey. In this short talk, Cameron Day, Commercial Director at ustwo, discusses how they created Alder Play to enhance the patient experience at Alder Hey Children's Hospital.


Patient Centricity on trial Keynote

Claire Knapp and Mark Evans, Havas Lynx Group

On Friday 3rd May 2019 we launched #LXAcademy 2019. In this keynote Mark Evans and Claire Knapp, Managing Directors at the Havas Lynx Group, discuss how bringing the patient experience front and centre in clinical trials could revolutionise trial design, recruitment and retention - ultimately improving outcomes.


talking to patients like people

Mark Evans, Managing Director, Havas Lynx Faze

Mark Evans, Managing Director of Havas Lynx Faze, recently gave a talk titled 'Talking To Patients Like People' to provide more background on the theme of this year's white paper, which will officially launch on Monday 20th May.


Patient Centricity On Trial

Today, 40 million patients are needed for over 300,000 clinical trials, worldwide. This year’s white paper explores how bringing the patient experience front and centre in clinical trials could revolutionise trial design, retention and recruitment – ultimately improving outcomes.